JP Morgan Chase
ANRO icon

JP Morgan Chase’s Alto Neuroscience ANRO Stock Holding History

JP Morgan Chase’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$919 Sell
46
-100
-68% -$1.85K ﹤0.01% 7133
2025
Q4 		$2.6K Buy
+146
New +$1.84K ﹤0.01% 6903
2025
Q2 		– Sell
-10,949
Closed -$23.6K – 7729
2025
Q1 		$23.6K Buy
10,949
+708
+7% +$2.53K ﹤0.01% 6105
2024
Q4 		$43.3K Sell
10,241
-14,074
-58% -$87.8K ﹤0.01% 6066
2024
Q3 		$278K Buy
24,315
+20,536
+543% +$251K ﹤0.01% 5246
2024
Q2 		$40.4K Sell
3,779
-21,218
-85% -$276K ﹤0.01% 5940
2024
Q1 		$384K Buy
+24,997
New +$391K ﹤0.01% 4967

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase's ANRO Position: Q1 2026 in Review

JP Morgan Chase reduced its Alto Neuroscience (ANRO) stake by 68% in Q1 2026, selling an estimated $1.85K and leaving 46 shares worth $919. The position accounts for ﹤0.01% of the portfolio, ranked #7133.

JP Morgan Chase first reported a position in ANRO in Q1 2024 and has held it in 7 quarters since. The position peaked at $384K in Q1 2024. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • JP Morgan Chase held 46 shares of Alto Neuroscience worth $919 as of Q1 2026.
  • JP Morgan Chase sold 100 Alto Neuroscience shares in Q1 2026, an estimated $1.85K.
  • Alto Neuroscience made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7133 holding.
  • JP Morgan Chase first reported a position in Alto Neuroscience in Q1 2024 and has held it in 7 quarters since.
  • JP Morgan Chase's Alto Neuroscience position peaked at $384K in Q1 2024.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.